3,787
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Tuberculosis relapse is more common than reinfection in Beijing, China

, , , , , & show all
Pages 858-865 | Received 01 Jan 2020, Accepted 03 Jul 2020, Published online: 16 Jul 2020

References

  • WHO. Global tuberculosis report 2019. Geneva: WHO; 2019.
  • Liu Y, Tian M, Wang X, et al. Genotypic diversity analysis of Mycobacterium tuberculosis strains collected from Beijing in 2009, using spoligotyping and VNTR typing. PLoS One. 2014;9(9):e106787.
  • Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057–2064.
  • Statistics BMBo. Resident population in Beijing 2017. [cited 2020 Jul 9]. Available from: http://www.bjstats.gov.cn/tjsj/cysj/201511/t20151109_311727.html.
  • Prevention CCfDCa, China DCBaMADoMoHotPsRo. National tuberculosis control programme guideline in China. Beijing, China: Peking Union Medical College Press; 2009.
  • Control BRIfT. 7114 TB cases were reported in Beijing in 2017. [cited 2020 Jul 9]. Available from: http://news.sina.com.cn/o/2018-03-16/doc-ifysiima1067650.shtml.
  • Bang D, Andersen AB, Thomsen VO, et al. Recurrent tuberculosis in Denmark: relapse vs. re-infection. The international journal of tuberculosis and lung disease: the official journal of the International Union against. Tuberc Lung Dis. 2010;14(4):447–453.
  • Marx FM, Dunbar R, Enarson DA, et al. The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study. Clin Infect Dis. 2014;58(12):1676–1683.
  • Shen X, Yang C, Wu J, et al. Recurrent tuberculosis in an urban area in China: relapse or exogenous reinfection? Tuberculosis (Edinb). 2017;103:97–104.
  • Chiang CY, Riley LW. Exogenous reinfection in tuberculosis. Lancet Infect Dis. 2005;5(10):629–636.
  • McIvor A, Koornhof H, Kana BD. Relapse, re-infection and mixed infections in tuberculosis disease. Pathog Dis. 2017;75(3). DOI:10.1093/femspd/ftx020
  • Zong Z, Huo F, Shi J, et al. Relapse versus reinfection of recurrent tuberculosis patients in a national tuberculosis specialized hospital in Beijing, China. Front Microbiol. 2018;9:1858.
  • Dale KD, Globan M, Tay EL, et al. Recurrence of tuberculosis in a low-incidence setting without directly observed treatment: Victoria, Australia, 2002-2014. Int J Tuberc Lung Dis. 2017;21(5):550–555.
  • Anaam MS, Alrasheedy AA, Alsahali S, Alfadly SO, et al. Rate and risk factors of recurrent tuberculosis in Yemen: a 5-year prospective study. Infect Dis (Lond). 2020;52(3):161–169.
  • Yang C, Shen X, Peng Y, et al. Transmission of Mycobacterium tuberculosis in China: a population-based molecular epidemiologic study. Clin Infect Dis. 2015;61(2):219–227.
  • Teeter LD, Kammerer JS, Ghosh S, Tuberculosis Epidemiologic Studies Consortium, et al. Evaluation of 24-locus MIRU-VNTR genotyping in Mycobacterium tuberculosis cluster investigations in four jurisdictions in the United States, 2006-2010. Tuberculosis (Edinb)). 2017;106:9–15.
  • Cox H, Kebede Y, Allamuratova S, et al. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance. PLoS Med. 2006;3(10):e384.
  • Yang C, Luo T, Shen X, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation. Lancet Infect Dis. 2017;17(3):275–284.
  • Zhdanov V, Bilenko N, Mor Z. Risk factors for recurrent tuberculosis among successfully treated patients in Israel, 1999-2011. Isr Med Assoc J. 2017;19(4):237–241.
  • Guerra-Assuncao JA, Houben RM, Crampin AC, et al. Recurrence due to relapse or reinfection with Mycobacterium tuberculosis: a whole-genome sequencing approach in a large, population-based cohort with a high HIV infection prevalence and active follow-up. J Infect Dis. 2015;211(7):1154–1163.
  • Interrante JD, Haddad MB, Kim L, et al. Exogenous reinfection as a cause of late recurrent tuberculosis in the United States. Ann Am Thorac Soc. 2015;12(11):1619–1626.
  • Bestrashniy J, Nguyen VN, Nguyen TL, et al. Recurrence of tuberculosis among patients following treatment completion in eight provinces of Vietnam: a nested case-control study. Int J Infect Dis. 2018;74:31–37.
  • Afshar B, Carless J, Roche A, et al. Surveillance of tuberculosis (TB) cases attributable to relapse or reinfection in London, 2002–2015. PLoS One. 2019;14(2):e0211972.
  • Middelkoop K, Bekker LG, Shashkina E, et al. Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatment. The international journal of tuberculosis and lung disease: the official journal of the International Union against. Int j Tuberc Lung Dis. 2012;16(11):1510–1516.
  • Shen G, Xue Z, Shen X, et al. The study recurrent tuberculosis and exogenous reinfection, Shanghai, China. Emerging Infect Dis. 2006;12(11):1776–1778.
  • Luzze H, Johnson DF, Dickman K, Tuberculosis Research Unit, et al. Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda. The international journal of tuberculosis and lung disease: the official journal of the International Union against. Int J Tuberc Lung Dis. 2013;17(3):361–367.
  • Schiroli C, Carugati M, Zanini F, et al. Exogenous reinfection of tuberculosis in a low-burden area. Infection. 2015;43(6):647–653.
  • Parvaresh L, Crighton T, Martinez E, et al. Recurrence of tuberculosis in a low-incidence setting: a retrospective cross-sectional study augmented by whole genome sequencing. BMC Infect Dis. 2018;18(1):265.
  • Pang Y, Zhou Y, Wang S, et al. Prevalence and risk factors of mixed Mycobacterium tuberculosis complex infections in China. J Infect. 2015;71(2):231–237.
  • Gan M, Liu Q, Yang C, et al. Deep whole-genome sequencing to detect mixed infection of Mycobacterium tuberculosis. PloS One. 2016;11(7):e0159029.